A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 6/8/2011

Posted by | 11:53pm on Wednesday, June 8, 2011

:
#socpharm…welcome to tonights socpharm session……

:
@ thanks for moderating #socpharm tonight Craig.

:
#socpharm..Please start w/intro & why you are interested in this topic. Wel assume that all tweets within #so… (cont) http://deck.ly/~dtGWc

:
#socpharm…..thanks for the opportunity eileen!

:
My name is Amith, and I’m an incoming pharmacy student hoping to learn more about the industry! #socpharm

:
I’m Michael Spitz, VP of Digital Strategy at Ignite Health, interested in all tech & communications ultimately benefiting patients #socpharm

:
I’m Eileen, enjoy #socpharm, working in #raredisease #epharma marketing.

:
Hi, Joe Hage, moderator for #MedDevice, providing mktg comm and lead gen for medical companies #socpharm #HPM

:
Hi everyone-I’m Krista & work in alumni relations for a med school. I enjoy social media & healthcare comms issues. #socpharm

:
From Bostonish where it is a beautiful evening; industry mtkg, highly interested in our positive evolution in healthcare… #socpharm

:
#socpharm….i’m craig engesser in healthcare alliance development at purdue pharma

:
@ bring it! #socpharm

:
Hi all, I’m Joshua and work as a communications consultant for a pharma development co outside of Philadelphia. Will be in & out #socpharm

:
#socpharm…anyone else on?…….i thougt we’d kick off tonight with the pfizer virtual clinical trial…have you seen the youtube video?

:
#socpharm <--- to #PhRMA11 folks, that is the hashtag for the social pharma chat I mentioned. May have been off by a letter

:
#socpharm…have to say the tiopic ws eileens\

:
Rich Meyer Marketing Linchpin and Corporate Marketing Contrarian #socpharm

:
#socpharm….lets try that again…i have to admit the topic is eileens….and it is an interesting one indeed

:
@ I heard you gave us the #socpharm tweetchat a shout out at #PhRMA11. Thanks!

:
@ Can you repost links for those in the group who haven’t seen the content? #socpharm

:
@ @ ditto send link please #socpharm

:
#socpharm…..http://youtu.be/0fEx5V45zp4

:
RT @: Pfizer pilots first online clinical trials http://abcnews.go.com/Business/wireStory?id=13785702 #socpharm

:
I thought the idea of a virtual clinical trial was a good one but I wonder how HCP’s feel about it #socpharm

:
I also think the idea is excellent — groundbreaking, in fact — but wonder about adherence issues #socpharm

:
Here’s the YouTube video http://youtu.be/0fEx5V45zp4 It explains whole concept of Pfizer virtual clin trial clearly #socpharm

:
http://bit.ly/lHWVUd #socpharm here is link to news

:
#socpharm….i hear ya rich…..it struck me as really creative but lots of questions….ie is self selection going to bias results?

PR_in_Pink” target=”_blank”>likeamythThe Convenience factor is huge. Obviously I don’t think it’s a replacement for real trials, but more as a supplement #socpharm

PR_in_Pink:
@ I thought the same-privacy might be a plus, but it relies heavily on responsible & diligent patients. #socpharm

:
The disease state is also important — much more challenging to do this in oncology, for example #socpharm

:
@ Yes and one wonders what the FDA is going to think about the results #socpharm

:
We’ll have to see how the trials go because sacrificing convenience for accuracy might be a dangerous route to go down. #socpharm

:
The idea of conducting clinical trials virtually is interesting. But how many types of product will this work for? #socpharm

:
@ Adherence is a problem since there’s literally less face time with the HCPs and trial handlers #socpharm

:
Here in CA they tried to allow nurses to Rx some drugs and docs fought it so I wonder if docs will fight virtual trials as well #socpharm

:
@ Good point !! #socpharm

:
Also wondering about the blood and urine sampling component, and how that ties into it #socpharm

:
Of course Pfizer wants to cut $1 billion from expenses in next two years so this could be a way to do that #socpharm

:
@ And the placebo effect and what other meds they are taking #socpharm

:
Clinical trial management and recruitment is already handled digitally, so this is a logical extension #socpharm

:
Another concern is security and protection of blindness. Much harder to control in an online trial. #socpharm

:
If you can recruit and manage clinical trials digitally, why not also implement them? #socpharm

:
Are clinical subjects qualified to administer their own tests? I have a feeling a lot of skewed data is going to emerge from this. #socpharm

:
I think it’s great+ez to follow. YouTube Mytrus 16-wk Paid Overactive Bladder Clin Trial 4 Women http://ow.ly/5dxio #socpharm

:
@ So then it could work for some drugs but it’s not the answer for all drugs including the 200+ in Oncology devel #socpharm

:
#socpharm…would have loved to be fly on wall when fda and pfe discussed the approach

:
I agree Pfizer made appropriate choice w/ non-life threatening yet embarrassing overactive bladder condition. #socpharm

:
In the near future I see automated diagnostics supplementing these virtual trials, reassuring the FDA et al #socpharm

:
That’s one reason why this may not work for all drugs. RT @ Are clinical subjects qualified to administer own tests? #socpharm

:
For Cialis we asked patients in clin trials to keep journal and that worked very well #socpharm

:
#socpharm….great point eileen…..maybe one size doesnt fit all but for this it can work?

:
Patients will be “fitted” with Dx gear going into the trail, automatically communicating back to the HQ with real time data #socpharm

:
RT @: So then it could work for some drugs but its not the answer for all drugs including the 200+ in Oncology devel #socpharm

:
Can anyone tell me if most clinical trials involve payment to patients? #socpharm

:
@ is there some controversy here? It seems straightforward to me. What am I missing? #socpharm

:
@ No they dont but they usually involve free medical care and tests #socpharm

:
@ Some do, some don’t #socpharm

:
@ I agree the Pfizer YouTube video is very well done. Sets expectations for patients clearly. #socpharm

:
The major theme coming out of SXSW was enabling real time patient diagnostics for healthcare — that would help here #socpharm

:
There is commercial running here in So Ca for clinical trial for new diabetes drug. Patient gets free checkup, meds and tests #socpharm

:
#socpharm….no controversay…just new and very different……

:
Imagine patients being “fitted” with dx gear, which would do all the monitoring — all they would have to do is administer #socpharm

:
@ I definitely agree. This method will be very useful for milder medications. Can’t wait to see Pfizer’s results. #socpharm

:
Pfizer is progressive in seeking digital solutions for other aspect of clinical trials, so cost isn’t the whole story #socpharm

:
Also, is this being done for a Phase 3 pivotal trial or for an earlier phase trial? #socpharm

:
This all dovetails into the amazing evolution of #mhealth, where we introduce it to clinical trial managment #socpharm

:
Digital’s success centers around utility — instantaneous transmission of information regardless of location #socpharm

:
The biggest challenge facing most clinical trials is simple convenience — it’s a hassle to participate #socpharm

:
Not most IM exp. Free drug, visits, labs RT @: Can anyone tell me if most clinical trials involve payment to patients? #socpharm

:
#socpharm….i underestand the speed element, but in blinded trial, is speed necessar?

:
Another benefit of digital for clinical trials is INTEGRATION — combine data input with management with analysis #socpharm

:
#socpharm I talked to the GlowCaps folks- cool adherence tech that would be helpful in trials. BTW-I have no interests in that co.

:
@ Not necessarily just milder, but easier to apply and test for needed results. #socpharm

:
#socpharm….i like the idea that patients will see their own results when completed..will make them feel included and part of the process.

:
Other opportunities abound: Create a “digital patient diary” for participants to log their adherence, feelings, etc. #socpharm

:
@ What do you think of Pfizer conducting 1st virtual clinical trial? http://ow.ly/5dxAE Join our #socpharm chat.

:
A company here in West Coast is actually developing container so HCP can determine electronically if patients are taking meds #socpharm

:
@ Yes! Feedback is vital — imagine the power of real time communication with the clinical trial managers, too #socpharm

:
The other great thing about this is that what they learn is going to be invaluable if they can build on it #socpharm

:
Flipside of adherence issue: Substitute digital communication for physical communication to improve compliance #socpharm

:
Agree! RT @: #socpharm I like idea that patients will c their own results when completed..will make them feel included & part…

:
Natural tie-in to patient adherence information / programs and product feedback post-launch. #socpharm

:
#socpharm..digial diary is cool….are they free text of check list? It could work against clinical trial sponsor

:
Expanded biometrics is also possible: Right now we get limited data — imagine the whole digital nine yards with no extra work #socpharm

:
RT @: A company here in West Coast is actually developing container so HCP can determine electronically if patients are taking meds #socpharm

:
I’m also wondering about selection criteria for participants — might that expand to prowess with cell phones and the web? #socpharm

:
#socpharm..i think adherance will get huge boost with technology and everyone carrying a pda

:
@ Thanks! You should join the #socpharm discussion on this topic. All welcome.

:
Soon patients will be able to do basic checks like BP and heart rate and record and send to doc electronically #socpharm

:
Intel is already working on that #socpharm

:
Digital diagnostics is at the heart of transforming clinical trials, so doing things virtually is logical and inevitable #socpharm

:
@ True, though they’ll still need to be instructed how to measure those things correctly. #socpharm

:
#socpharm..does anyone know timeline for the pfe trial?….now i cant wait to hear about results

:
PFE virtual trial=great idea, adherence scares me, if results r good, publish and present.IF bad, data set will b buried #socpharm

:
seroquel trial pays $450 #socpharm @ http://www.cornellpsychiatry.com/research/current_clinical_trials.html #Bipolar

:
The number 1 thing patients want in med devices is ease of operation and they are willing to pay for it #socpharm http://bit.ly/jEbfOq

:
Similar to GlowCaps? RT @: #socpharm A company here in West Coast is actually developing containe… (cont) http://deck.ly/~HjwXq

:
Inputs are now limited for relevant clinical trial data — as digital expands depth & breadth of data, could that change trials? #socpharm

:
I can actually foresee the clinical trials themselves changing as the technology to measure and share data evolves #socpharm

:
Hell the FDA is questioning just about all clinical trial data now so it will be interesting to see #socpharm

:
if you can measure everything, why not? And if you can, what data becomes relevant? #socpharm

:
@ Not sure but it looks promising for caregivers and HCPs #socpharm

:
And if you can measure everything, what about the analysis — and viable conclusions about efficacy/safety? #socpharm

:
#socpharm….i wonder how docs feel about all this….

:
The other issue is that a LOT of clin trials are conducted outside of US to save $$$ #socpharm

:
The FDA is already struggling with how to regulate #mhealth apps — this could open up a whole new area of excitement — & concern #socpharm

:
FDA will likely be a late adopter to tech to+adherence in trial review b/c of medicaid/care and low income pop’s access to tech #socpharm

:
@ Very true, OUS trials are common — making them cheaper and simpler at home could change that #socpharm

:
#socpharm http://www.pharmalot.com/2011/06/pfizer-and-a-clinical-trial-in-a-box-for-home-use/ @ has a poll up re trial in a box

:
RT @: FDA will likely be a late adopter to tech to+adherence in trial review b/c of medicaid/care and low income pop’s access to tech #socpharm

:
#socpharm..@pharma411…agree it speaks to selection criteria

:
#socpharm….kinda funny hearing

:
btw i’m a mom, caregiver, advocate and blogger, just lurking today #socpharm the poll at pharmalot shows 50/50 trial in a box is good idea?

:
Tx for sharing, votes split re good idea RT @: #socpharm @ has a poll up re trial in a box http://ow.ly/5dxRb

:
Tech that reveals good adherence and good efficacy should be embraced. Talk about a mktg opp for me-too brands #socpharm

:
@ That is NOT where they do them they do them in inpovereshed countries where they can get people cheaply #socpharm

:
Although HCPs, the FDA, and even patients might be skeptical, virtual clinical trials will evolve and become routine #socpharm

:
#socpharm…its kinda funny reading trial in a box as we used to have “launch in a box” for product launches!

:
@ FDA is slow to adopt to technology for a whole lot of reasons, access to the technology among them #socpharm

:
Remember that adherence for even cancer drugs can be alarmingly high #socpharm

:
The only caveat is administration — IV for onco, for example — but watch as biometrics technology goes into the infusion suite #socpharm

:
The other issue is quality of life. Who really wants to be a guinnea pig for potential bad drug side effects #socpharm

:
RT @: The FDA is already struggling with how to regulate #mhealth apps — this could open up a whole new area of excitement — & concern #socpharm

:
As clinical trials become easier to participate in, watch recruiting problems dimish #socpharm

:
Recruitment is a huge issue now — combine digital recruting with management and implementation to creatre Clinical Trial CRM! #socpharm

:
@ Not just administration, but measuring the necessarily vitals, bloodwork etc. Do subjects know how to do it right? #socpharm

:
#socpharm…this is raising another issue….privacy of data and info…..will people consider that a barrier to participate?

:
working with biotech comp here to try and do clin trials on Web and they are struggling to find people who want to participate #socpharm

:
@ I was amazed to learn that non adherence is issue for transplant patients w/anti-rejection drugs! Prob across the board #socpharm

:
@ I doubt the chemos will ever be self-administered (although you never know); but tech can help the process at clinics #socpharm

:
Interesting idea, but w/ many questions Pfizer Starts1st US “Virtual” Clinical Study – ABC News http://t.co/UbTSsbh #in #socpharm #fdasm

:
Re privacy, did anyone hear any pushback resulting from Epsilon data leak of email addresses & medical conditions? #socpharm

:
If the privacy hurdle can be overcome in #mhealth, then then same rules apply for virtual clinical trials #socpharm

:
You all might want to read Time Mag this week has good articles about develop of new cancer drugs and how patients are saying No #socpharm

:
#socpharm..@rich….anything in particular that is keeping people away?

:
Let’s not forget pharma trends toward targeted therapies and micro-populations/orphan drugs: Digital trials could help there, too #socpharm

:
@ @ Yes side effects that are unknown. If it interferes with quality of life they dont want to know #socpharm

:
@ @ Other issue is that it requires them to either go to doctor or record info and they dont want to be bothered #socpharm

:
Chemos are often expensive, have tolerability issues, and extended survival can be as little as a few months #socpharm

:
#socpharm….our zero tolerance society at work!…..but i can appreciate concern

:
Targeted therapies, tailored treatment is the future, especially for oncology; so dx becomes even more vital #socpharm

:
#socpharm Interested in Pharma reps with iPads-I completed some research. Free 2nite to this group=PDF http://tinyurl.com/6b3dg4h

:
Imagine detailed, comprehensive digital profiles of participants, helping fine-tune eligibility — and analysis #socpharm

:
Study is called Pursuit of Value #socpharm

:
@ Given how long the FDA is taking to put out a social media guidance, probably concern. FDA is slow with technology. #socpharm

:
By the way some of warnings on clinical trial drugs are more than scary #socpharm

:
As we learn more about patients, drugs, and how they match up in terms of efficacy/tolerability, we can build better trials #socpharm

:
#socpharm…..@eileen….can NORD help?

:
Let’s not forget GEOLOCATION — if a clinical trial is virtual, you can pull from a vast demographic #socpharm

:
Absolutely, if want to be in a #raredisease clinical trial but live in geographically isolated area, virtual trial might enable #socpharm

:
@ WOW great thanks..great info #socpharm

:
Freedom from geographical constraints is perhaps the number one reason virtual clinical trials will take off #socpharm

:
RT @: Absolutely, if want to be in a #raredisease clinical trial but live in geographically isolated area, virtual trial might enable #socpharm

:
@ Not surprised, since they haven’t been completely tested yet. Have to really err on side of caution there. #socpharm

:
And that geographical freedom dovetails back into improving recruitment, management, and adherence #socpharm

:
Having worked FDA, we could turn this into a comedy show with some reasons! RT @: : #socpharm … (cont) http://deck.ly/~Lfu5P

:
Full circle: Imagine an administration device that’s programmed to automatically dose, tied to the biometrics of the trial? #socpharm

:
#socpharm Thx- have a gr8 nite. Off to watch Bruins beat Vancouver!

:
Take the “human variable” out of the data input, transmission, and analysis — would the FDA buy that and be assured? #socpharm

:
#socpharm….GO Bruins!!!!!

:
Wow, time flew by tonight. Thanks @ for leading a great #socpharm chat. I’ll share transcript tomorrow.

:
#socpharm.@spitz….you are a man ahead of his time!!!

:
@ Thanks for hosting! Fun chat — We certainly live in interesting times! #socpharm

:
#socpharm….thank you for the opportunity!….thanks everyone for great chat tonight and for all the participation!…..

:
See you next joshdbrett: @ Thanks for hosting. Glad I finally got to participate in this. #socpharm

:
I had the pleasure of seeing @ present — she’s terrific #socpharm

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com